DPLO Insider Trading Activity and SEC Form 4 Filings
DPLO insider trading summary
No open-market insider purchases or sales of Diplomat Pharmacy, Inc. (DPLO) have been reported on SEC Form 4 in the past 12 months.
Latest DPLO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 2, 2019 | Benjamin Wolin | Director | Sell | $4K (859 @ $4.84) |
| Oct 2, 2019 | Kenneth O Klepper | Director | Sell | $4K (859 @ $4.84) |
| Oct 2, 2019 | Regina M. Benjamin | Director | Sell | $4K (859 @ $4.84) |
| Oct 2, 2019 | Philip R Hagerman | Director | Sell | $13K (2,610 @ $4.80) |
| Oct 2, 2019 | Shawn Tomasello | Director | Sell | $4K (859 @ $4.84) |
| Oct 2, 2019 | David C Dreyer | Director | Sell | $4K (860 @ $4.82) |
| Jun 4, 2019 | Kenneth O Klepper | Director | Sell | $6K (1,274 @ $4.85) |
| Jun 4, 2019 | David C Dreyer | Director | Sell | $6K (1,274 @ $4.85) |
| Jun 4, 2019 | Benjamin Wolin | Director | Sell | $6K (1,274 @ $4.85) |
| Jun 4, 2019 | Regina M. Benjamin | Director | Sell | $6K (1,274 @ $4.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.